| Han, Yaling |
NCT03287167: Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease |
|
|
| Recruiting | 4 | 1720 | RoW | 1 month DAPT, 6 months DAPT | Shanghai MicroPort Medical (Group) Co., Ltd. | Coronary Disease, Drug Eluting Stent, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy | 07/21 | 07/23 | | |
| Active, not recruiting | 3 | 428 | RoW | MiStent, TIVOLI | Micell Technologies, Hefei Life Science Medical Instruments Co. Ltd., Giant Med-Pharma Services Inc., CCRF Consulting Co., Ltd. | Coronary Heart Disease | 11/18 | 11/22 | | |
NCT04781114: The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia |
|
|
| Completed | 3 | 806 | RoW | JS002, Placebo | Shanghai Junshi Bioscience Co., Ltd. | Hyperlipemia | 05/22 | 01/23 | | |
VCP1-III-01, NCT06577519: Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) |
|
|
| Recruiting | 3 | 1000 | RoW | Vicagrel, Clopidogrel | Jiangsu vcare pharmaceutical technology co., LTD | Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) | 12/26 | 12/26 | | |
PADN-HF-PH, NCT05824923: A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure |
|
|
| Recruiting | 3 | 264 | RoW | Pulmonary arterial denervation, PADN, Guideline-directed medical therapy (GDMT) for heart failure, GDMT medication for heart failure | Pulnovo Medical (Wuxi) Co., Ltd., The General Hospital of Northern Theater Command, The First Affiliated Hospital with Nanjing Medical University, First Hospital of Tsinghua University, Cangzhou Central Hospital, Fuwai Central China Cardiovascular Hospital, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Guangzhou Medical University, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, Second Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Shanxi Cardiovascular Hospital, RenJi Hospital, Shanghai 10th People's Hospital, Beijing Anzhen Hospital, West China Hospital, Sichuan Academy of Medical Sciences, The First Affiliated Hospital of Soochow University, TEDA International Cardiovascular Hospital, Tianjin Medical University General Hospital, Renmin Hospital of Wuhan University, Zhongnan Hospital of Wuhan University, First Affiliated Hospital Xi'an Jiaotong University, Xiamen Cardiovascular Hospital, Xiamen University, Zhejiang University, Shengjing Hospital, First Affiliated Hospital of Fujian Medical University, First Affiliated Hospital of Wenzhou Medical University, Gansu Provincial Hospital, Yanan Hospital of Kunming City, First Affiliated Hospital of Chongqing Medical University, Huaihe Hospital of Henan University, Zhengzhou Cardiovascular Hospital, Wuhan Union Hospital, China, The First Affiliated Hospital of Nanchang University, Hunan Provincial People's Hospital, Tianjin Medical University Second Hospital, First Affiliated Hospital, Sun Yat-Sen University, The First Hospital of Jilin University | Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension, Vascular Diseases, Cardiovascular Diseases, Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction | 08/25 | 02/27 | | |
NCT06339021: OCT or Angiography Guided De-escalation of DAPT |
|
|
| Not yet recruiting | 1 | 80 | RoW | OCT-guided PCI, Conventional angiography-based PCI, DAPT de-escalation, default DAPT regimen | Shenyang Northern Hospital | Optical Coherence Tomography, Dual Antiplatelet Therapy, Antiplatelet De-escalation, Neointimal Coverage, ST Elevation Myocardial Infarction | 12/26 | 12/26 | | |
NCT03040934: Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s) |
|
|
| Active, not recruiting | N/A | 196 | RoW | Firehawk sirolimus target eluting coronary stent system, Firehawk™, XIENCE Everolimus-Eluting Coronary Stent System, XIENCE EES | Shanghai MicroPort Medical (Group) Co., Ltd. | Drug-Eluting Stents, Percutaneous Coronary Intervention, Tomography, Optical Coherence | 09/19 | 10/23 | | |
NCT04569669: The Sensitivity and Specificity of CardioSimFFRct Analysis Software on Coronary Artery Stenosis |
|
|
| Not yet recruiting | N/A | 325 | RoW | FFR and FFRCT | CCRF Inc., Beijing, China, Shengshi Technology, Co., Ltd, Hangzhou, China | Coronary Stenosis | 10/21 | 03/22 | | |
SIBLINT ISR, NCT04240444: Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis |
|
|
| Completed | N/A | 260 | RoW | drug-coated balloon Catheter | B. Braun Medical International Trading Company Ltd., CCRF Inc., Beijing, China | Coronary Artery Disease, In Stent Restenosis | 07/22 | 08/22 | | |
| Not yet recruiting | N/A | 220 | RoW | Paclitaxel-Eluting Coronary Balloon Dilation Catheter (DIOR), Paclitaxel-Eluting Balloon (Bingo) | CCRF Inc., Beijing, China | Percutaneous Coronary Intervention | 05/22 | 10/22 | | |
BRIGHT-4, NCT03822975: Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI |
|
|
| Active, not recruiting | N/A | 6016 | RoW | Bivalirudin, unfractionated Heparin | Shenyang Northern Hospital | ST Elevation Myocardial Infarction | 05/22 | 05/23 | | |
| Recruiting | N/A | 20 | RoW | SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System | Shanghai Shenqi Medical Technology Co., Ltd | Mitral Regurgitation | 10/22 | 10/26 | | |
NCT05375110: NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure) |
|
|
| Recruiting | N/A | 120 | RoW | NoYAâ„¢ Radiofrequency Interatrial Shunt System | Hangzhou NOYA MedTech Co. Ltm. | Heart Failure | 12/22 | 12/23 | | |
NCT05015712: Effects of MICT on Cardiopulmonary Function in Patients After TAVI |
|
|
| Recruiting | N/A | 66 | RoW | moderate intensity continuous training | Han Yaling, MD | Valve Disease, Aortic, Cardiac Rehabilitation | 06/23 | 06/23 | | |
NCT05988450: Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation |
|
|
| Active, not recruiting | N/A | 125 | RoW | SQ-Kyrin Transcatheter Mitral Valve Repair System | Shanghai Shenqi Medical Technology Co., Ltd | Functional Mitral Regurgitation | 12/23 | 12/27 | | |
| Not yet recruiting | N/A | 3490 | RoW | standard DAPT, OPT-CAD score guided DAPT de-escalation | Shenyang Northern Hospital | Acute Coronary Syndrome | 12/25 | 12/25 | | |
| Not yet recruiting | N/A | 10000 | RoW | | Shenyang Northern Hospital | Coronary Heart Disease (CHD) | 10/26 | 10/30 | | |
NCT06357026: Phitys I™ Percutaneous Left Ventricular Assist System Study |
|
|
| Not yet recruiting | N/A | 344 | RoW | Percutaneous Ventricular Assist System（Phigine Medical）, intra-aortic balloon pump (IABP) | Shanghai NewMed Medical Co., Ltd., Shanghai Phigine Medical Technology Co., Ltd. | Coronary Artery Disease | 05/25 | 04/26 | | |
NCT05864456: Prizvalve Pro™ Transcatheter Aortic Valve Replacement Study |
|
|
| Recruiting | N/A | 73 | RoW | Prizvalve Pro™ transcatheter aortic valve system | Shanghai NewMed Medical Co., Ltd., The General Hospital of Northern Theater Command, West China Hospital | Aortic Valve Stenosis | 06/24 | 05/28 | | |
| Recruiting | N/A | 3600 | RoW | SGLT-2 inhibitors | Shenyang Northern Hospital | Impact of SGLT2-inhibitors on PC-AKI in ACS Patients Receiving Invasive Strategy | 12/24 | 12/24 | | |
NCT06101888: Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR) |
|
|
| Recruiting | N/A | 116 | RoW | TaurusTrio™ Heart Valve System | Peijia Medical Technology (Suzhou) Co., Ltd. | Aortic Regurgitation | 07/24 | 07/29 | | |
| Not yet recruiting | N/A | 10 | RoW | DragonFire Transcatheter Myocardial Radiofrequency Ablation System | Hangzhou Valgen Medtech Co., Ltd | Obstructive Hypertrophic Cardiomyopathy | 06/25 | 06/26 | | |
NCT06639321: Phimume® Percutaneous Left Ventricular Assist System Study |
|
|
| Not yet recruiting | N/A | 250 | RoW | Percutaneous Ventricular Assist System, extracorporeal membrane oxygenation (ECMO) | Shanghai NewMed Medical Co., Ltd., Shanghai Phigine Medical Technology Co., Ltd. | Coronary Artery Disease | 11/25 | 10/26 | | |
NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus |
|
|
| Recruiting | N/A | 184 | RoW | Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter | Shanghai Bluesail Boyuan Medical Technology Co., Ltd. | Coronary Artery Disease, Intravascular Lithotripsy | 12/24 | 09/25 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
CRUISE-CTO, NCT04944615: To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease. |
|
|
| Recruiting | N/A | 1448 | RoW | The guidewire successfully passed the CTO lesion, Load dose administration | CCRF Inc., Beijing, China, BSC International Medical Trading (Shanghai) Co., Ltd. | Chronic Total Occlusion of Coronary Artery | 10/31 | 10/31 | | |
| Not yet recruiting | N/A | 1029 | RoW | clonal hematopoiesis of indeterminate potential | Shenyang Northern Hospital | ACS, Clonal Hematopoiesis of Indeterminate Potential, Smoking Cessation | 08/23 | 08/24 | | |
| Yaling, Han |
| Not yet recruiting | N/A | 220 | RoW | Paclitaxel-Eluting Coronary Balloon Dilation Catheter (DIOR), Paclitaxel-Eluting Balloon (Bingo) | CCRF Inc., Beijing, China | Percutaneous Coronary Intervention | 05/22 | 10/22 | | |
